Table: Zeria Pharm -2024/25 group results

Zeria Pharmaceutical

08/05/2025 08:00

May 8 (Reuters)- 
          Zeria Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           87.31           75.73          90.00        43.00    
               (+15.3 pct)     (+10.7 pct)    (+3.1 pct)    (+1.4 pct) 
  Operating       12.20            9.62          12.00         5.00    
               (+26.8 pct)     (+6.7 pct)     (-1.6 pct)   (-22.6 pct) 
  Recurring       12.84            8.51          12.00         5.00    
               (+50.8 pct)     (+12.3 pct)    (-6.5 pct)   (-37.1 pct) 
  Net
  Net              9.94            7.73           9.50         4.00    
               (+28.5 pct)     (+24.8 pct)    (-4.4 pct)   (-34.0 pct) 
  EPS          225.42 yen      175.39 yen     215.52 yen    90.75 yen  
  Ann Div       47.00 yen       44.00 yen      48.00 yen               
  -Q2 Div       23.00 yen       22.00 yen      24.00 yen               
  -Q4 Div       24.00 yen       22.00 yen      24.00 yen               
  
  NOTE - Zeria Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T